Adaptive Care Transition — Strategy Sprint
The thirty-day blindness.
In the hospital
Full clinical visibility
→
At home
The caregiver, invisible
→
Day 30
A preventable readmission
You have clinical visibility before discharge. You lose it the moment they go home — for the thirty days when readmission risk is highest.
The cost of blindness
What post-acute readmissions really cost.
20–25%of Medicare discharges readmit within 30 days
30–40%of those are caregiver-driven — stress, confusion, escalation delay
Not non-compliance. Not bad luck.
What stays invisible
Stress patterns that precede escalation by days
Medication slips from overload, not refusal
Decisions made alone, at three in the morning
Staff anxiety about what happens after discharge
You cannot intervene on what you cannot see.
The caregiver paradox
We have been optimizing the wrong question.
What we measure
Did the patient understand?
Was the referral submitted?
Were the boxes checked?
Task completion.
What predicts readmission
Is the caregiver overloading?
Are they recovering between demands?
Can they still learn and decide?
Nervous-system state.
What if you could see it?
Early warning for the invisible crisis.
The thirty days after discharge
Discharge
Day 5–7 · rising strain
Patient stays home
You would intervene before the panic — and prevent the readmission.
Our approach
Behavioral systems mapping.
01
Workflow Intelligence
Map the discharge journey as it is actually lived — where coordination breaks, and where the caregiver absorbs invisible burden.
02
Caregiver Burden Mapping
Locate the stress-point moments, and read caregiver state through behavioral and physiological markers, including HRV.
03
Adaptive Intervention Design
Design low-friction support timed to the pre-escalation window — a deliverable response your team can carry, not another app.
What we deliver
A ten-week sprint, in four phases.
Weeks 1–2Discovery
Map the workflow, set baseline metrics, define the caregiver cohort.
Weeks 2–6Proof
A caregiver cohort uses a simple app through the critical window. We test whether escalation is predictable.
Weeks 5–8Design
Turn what caregivers showed us into workflow changes, staff training, and measurement.
Weeks 8–14Results
Run the pilot, measure outcomes, deliver the analysis, case study, and roadmap.
You don't just get recommendations. You get evidence, a blueprint, and a case study.
The proof layer
We don't ask you to bet on a framework. We prove it.
A small cohort of your caregivers uses a simple app through the thirty-day window. Stress state, friction, and HRV are read via Somatag or compatible wearables. When pre-escalation signals appear, we trigger a quiet micro-intervention.
Proof it predictsthat caregiver stress patterns precede escalation.
Evidence it worksbefore you commit to scaling it.
A case studyfrom your own population, to fund what comes next.
What success could look like
Illustrative scenario — modeled figures, not a completed engagement
A heart-failure cohort at 25% readmission.
~18%lower 30-day readmission (25% → ~20.5%)
~40%fewer post-discharge escalation events
~30%improvement in caregiver burden scores
5–7dadvance warning before a readmission event
These figures model the kind of change the approach is designed to produce. A live engagement is how they would be tested.
Who this is for
The right partner for this work.
This engagement fits systems that
Carry high readmission in a specific post-acute cohort
See caregiver capacity as clinical, not only logistical
Want to move from reactive management to prevention
Are ready to pilot with clear outcomes and a scaling plan
Why Kutuhala
HRV and behavioral research, grounded in a multi-year caregiver study
Interventions that integrate into your workflow, not add to it
Replicable blueprints — caregivers as clinical assets, not variables
The engagement
Structure, scope, and timeline.
What's included
The full Kutuhala team — research, strategy, design, analysis
All deliverables across the four phases
Weekly check-ins and monthly steering committee
A publication-ready case study
Timeline
10 weeks
active, with two to four weeks after for case-study finalization.
Investment is sized to your cohort and shared in a first conversation.
What happens next
A phased path to scale.
This engagementProve it
Strategy sprint, pilot, and an evidence-based blueprint.
Months 3–6Implement
Roll out across the primary cohort; measure at scale; refine.
Months 6+Build infrastructure
Somatag or a caregiver app as an institutional tool; expand cohorts.
In parallelPosition
Publish the findings; present; lead on caregiver-centered care.
One system. One cohort. One proof point. Then you scale it.
Why now
The emerging frontier of post-acute care.
The urgency
Readmission penalties are real and growing
Caregiver burnout is at crisis levels
Payers are demanding innovation in post-acute care
The opportunity
Early movers set the standard for caregiver-centered design
The work is publishable — clinical and operational credibility
The approach scales across cohorts — cardiac, stroke, orthopedic
Most systems are optimizing process. Few are treating the caregiver as a clinical asset.
The invitation
The patient is discharged. The care is not.
What if you could see the break coming — and intervene before the crisis? This engagement is designed to answer that with evidence. Your data. Your caregivers. Your outcomes.
The next step
A ninety-minute working session with your clinical team.